These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 9779717

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Acute myelogenous leukemia after treatment for malignant germ cell tumors in children.
    Schneider DT, Hilgenfeld E, Schwabe D, Behnisch W, Zoubek A, Wessalowski R, Göbel U.
    J Clin Oncol; 1999 Oct; 17(10):3226-33. PubMed ID: 10506623
    [Abstract] [Full Text] [Related]

  • 6. Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.
    Smith MA, Rubinstein L, Ungerleider RS.
    Med Pediatr Oncol; 1994 Oct; 23(2):86-98. PubMed ID: 8202047
    [Abstract] [Full Text] [Related]

  • 7. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins.
    Smith MA, Rubinstein L, Anderson JR, Arthur D, Catalano PJ, Freidlin B, Heyn R, Khayat A, Krailo M, Land VJ, Miser J, Shuster J, Vena D.
    J Clin Oncol; 1999 Feb; 17(2):569-77. PubMed ID: 10080601
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies.
    Kollmannsberger C, Hartmann JT, Kanz L, Bokemeyer C.
    J Cancer Res Clin Oncol; 1998 Feb; 124(3-4):207-14. PubMed ID: 9619748
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy.
    Beyer J, Kingreen D, Krause M, Schleicher J, Schwaner I, Schwella N, Huhn D, Siegert W.
    Cancer; 1997 Jan 01; 79(1):161-8. PubMed ID: 8988741
    [Abstract] [Full Text] [Related]

  • 15. Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.
    Beyer J, Rick O, Weinknecht S, Kingreen D, Lenz K, Siegert W.
    Bone Marrow Transplant; 1997 Nov 01; 20(10):813-9. PubMed ID: 9404920
    [Abstract] [Full Text] [Related]

  • 16. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
    Kröger N, Damon L, Zander AR, Wandt H, Derigs G, Ferrante P, Demirer T, Rosti G, Solid Tumor Working Party of the European Group for Blood and Marrow Transplantation, German Adjuvant Breast Cancer Study Group, University of California, San Francisco.
    Bone Marrow Transplant; 2003 Dec 01; 32(12):1153-7. PubMed ID: 14647269
    [Abstract] [Full Text] [Related]

  • 17. Treatment of testicular cancer and the development of secondary malignancies.
    Bokemeyer C, Schmoll HJ.
    J Clin Oncol; 1995 Jan 01; 13(1):283-92. PubMed ID: 7799032
    [Abstract] [Full Text] [Related]

  • 18. Therapy-related acute myeloid leukemia and myelodysplastic syndrome among refractory germ cell tumor patients.
    Inoue Y, Nakamura T, Nakanishi H, Oishi M, Hongo F, Okihara K, Mizutani S, Kuroda J, Ukimura O.
    Int J Urol; 2018 Jul 01; 25(7):678-683. PubMed ID: 29752743
    [Abstract] [Full Text] [Related]

  • 19. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schöffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C, German Testicular Cancer Study Group.
    J Clin Oncol; 2003 Nov 15; 21(22):4083-91. PubMed ID: 14568987
    [Abstract] [Full Text] [Related]

  • 20. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
    Pedersen-Bjergaard J, Philip P, Larsen SO, Andersson M, Daugaard G, Ersbøll J, Hansen SW, Hou-Jensen K, Nielsen D, Sigsgaard TC.
    Leukemia; 1993 Dec 15; 7(12):1975-86. PubMed ID: 8255096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.